Open AccessTirzepatide: Does the Evidence to Date Show Potential for the Treatment of Early Stage Type 2 Diabetes?
Author(s) -
Tanzila S Razzaki,
Alyson Weiner,
Alpana P. Shukla
Publication year - 2022
Publication title -
therapeutics and clinical risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.719
H-Index - 55
eISSN - 1178-203X
pISSN - 1176-6336
DOI - 10.2147/tcrm.s328056
Subject(s) - medicine , type 2 diabetes mellitus , diabetes mellitus , glucagon like peptide 1 receptor , type 2 diabetes , glycemic , agonist , endocrinology , placebo , receptor , insulin , pharmacology , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom